Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 28, 2026 in Tenax Therapeutics, Inc. Lawsuit - TENX

Levi & Korsinsky, LLP is reminding shareholders of Tenax Therapeutics, Inc. (NASDAQ: TENX) that a lead plaintiff deadline of December 28, 2026, is approaching for a pending securities class action lawsuit. The lawsuit covers shares acquired between November 13, 2023, and August 7, 2026, alleging that Tenax made misleading statements regarding the efficacy and prospects of its drug TNX-103, particularly concerning its Phase 3 LEVEL study which ultimately failed to meet its primary endpoint. Investors who purchased shares during this period may be eligible to recover losses and are encouraged to contact Levi & Korsinsky for an assessment.